Literature DB >> 20473716

The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment.

Di Jin1, Feng Wang, Lijun Qu, Zhituo Li, Lianhong Jin, Ping Liu, Xiaolin Xu, Hao Cui.   

Abstract

The purpose of this study is to investigate the distribution and expression of the tight junction membrane proteins, claudin-5 and occludin, in rat blood-optic nerve barrier after borneol treatment. Seventy-two female Wistar rats were randomly divided into the borneol gastric lavage group and the equal volume solvent gastric lavage control group. The bilateral optic nerve from the retrobulbar region to the optic chiasma was collected from the rats in the two groups before gastric lavage and at 30 min, 1, 2, 4, and 8 h after gastric lavage. The distribution and expression of claudin-5 and occludin were detected using immunofluorescence staining, Western blotting, and reverse transcription polymerase chain reaction (RT-PCR). Results showed that claudin-5 translocated from the cell membrane to the cytoplasm at 30 min following initiation of borneol treatment, and this translocation peaked at 1 h. During this period of time, a small amount of occludin also translocated from the cell membrane to the cytoplasm. Four hours after initiation of treatment, claudin-5 and occludin levels in the cytoplasm began to decrease and were restored to their normal pattern 8 h after initiation of treatment. There were no significant differences in the levels of claudin-5 or occludin before or after treatment in either group. It was concluded that claudin-5 and occludin translocate within cells of the rat blood-optic nerve barrier after borneol treatment, and this translocation was reversible. Claudin-5 may play a potential role in permeability of the blood-optic nerve barrier following borneol treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473716     DOI: 10.1007/s11033-010-0184-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

Review 1.  Delivery of peptides and proteins through the blood-brain barrier.

Authors:  U Bickel; T Yoshikawa; W M Pardridge
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation.

Authors:  Margaret A Petty; Eng H Lo
Journal:  Prog Neurobiol       Date:  2002-12       Impact factor: 11.685

3.  [Effect of borneol on the intercellular tight junction and pinocytosis vesicles in vitro blood-brain barrier model].

Authors:  Yan-ming Chen; Ning-sheng Wang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2004-07

4.  Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.

Authors:  Y S Kang; U Bickel; W M Pardridge
Journal:  Drug Metab Dispos       Date:  1994 Jan-Feb       Impact factor: 3.922

5.  Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC.

Authors:  Jorge I Alvarez; Judy M Teale
Journal:  J Neuroimmunol       Date:  2006-01-06       Impact factor: 3.478

6.  Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells.

Authors:  S Liebner; U Kniesel; H Kalbacher; H Wolburg
Journal:  Eur J Cell Biol       Date:  2000-10       Impact factor: 4.492

7.  Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP.

Authors:  Tamotsu Soma; Hideki Chiba; Yuko Kato-Mori; Takuro Wada; Toshihiko Yamashita; Takashi Kojima; Norimasa Sawada
Journal:  Exp Cell Res       Date:  2004-10-15       Impact factor: 3.905

8.  Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways.

Authors:  Tsutomu Ishizaki; Hideki Chiba; Takashi Kojima; Masato Fujibe; Tamotsu Soma; Hideaki Miyajima; Kunihiko Nagasawa; Ikuo Wada; Norimasa Sawada
Journal:  Exp Cell Res       Date:  2003-11-01       Impact factor: 3.905

9.  Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins.

Authors:  M Itoh; M Furuse; K Morita; K Kubota; M Saitou; S Tsukita
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

10.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice.

Authors:  Mikio Furuse; Masaki Hata; Kyoko Furuse; Yoko Yoshida; Akinori Haratake; Yoshinobu Sugitani; Tetsuo Noda; Akiharu Kubo; Shoichiro Tsukita
Journal:  J Cell Biol       Date:  2002-03-11       Impact factor: 10.539

View more
  5 in total

1.  Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.

Authors:  Qun-Lin Zhang; Bingmei M Fu; Zhang-Jin Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 2.  Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective.

Authors:  Quanguo He; Jun Liu; Jing Liang; Xiaopeng Liu; Wen Li; Zhi Liu; Ziyu Ding; Du Tuo
Journal:  Cells       Date:  2018-03-23       Impact factor: 6.600

3.  The Role and Mechanism of Borneol to Open the Blood-Brain Barrier.

Authors:  Tao Wu; Aiqin Zhang; Hongyang Lu; Qiaoyuan Cheng
Journal:  Integr Cancer Ther       Date:  2018-04-13       Impact factor: 3.279

Review 4.  Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.

Authors:  Jinxiu Li; Qian Xie; Rong Ma; Yong Li; Jianmei Yuan; Mihong Ren; Hongyan Li; Jiajun Wang; Danni Lu; Zhuo Xu; Jian Wang
Journal:  Front Med (Lausanne)       Date:  2021-11-25

5.  Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer.

Authors:  Zheng Cai; Xiaolu Lei; Zhufen Lin; Jie Zhao; Feizhen Wu; Zhaoxiang Yang; Junxue Pu; Zhongqiu Liu
Journal:  Acta Pharm Sin B       Date:  2014-01-24       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.